Share Name Share Symbol Market Type Share ISIN Share Description
Jtc LSE:JTC London Ordinary Share JE00BF4X3P53 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -3.00p -0.76% 390.00p 70,116 16:27:03
Bid Price Offer Price High Price Low Price Open Price
381.00p 390.00p 395.00p 380.00p 380.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial - - - - 416.90

Jtc (JTC) Latest News (1)

More Jtc News
Jtc Takeover Rumours

Jtc (JTC) Share Charts

1 Year Jtc Chart

1 Year Jtc Chart

1 Month Jtc Chart

1 Month Jtc Chart

Intraday Jtc Chart

Intraday Jtc Chart

Jtc (JTC) Discussions and Chat

Jtc Forums and Chat

Date Time Title Posts
22/6/201823:22JTCod's Blog67,289
20/3/201812:01JTC Group IPO March 18 1
19/2/200122:18JTC - up 20% wow . nm3

Add a New Thread

Jtc (JTC) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-06-22 15:52:18391.554001,566.19O
2018-06-22 15:35:06390.003,46613,517.40UT
2018-06-22 15:29:05390.00120468.00AT
2018-06-22 15:29:05390.008863,455.40AT
2018-06-22 15:27:03390.00225877.50AT
View all Jtc trades in real-time

Jtc (JTC) Top Chat Posts

Jtc Daily Update: Jtc is listed in the General Financial sector of the London Stock Exchange with ticker JTC. The last closing price for Jtc was 393p.
Jtc has a 4 week average price of 374p and a 12 week average price of 295p.
The 1 year high share price is 420p while the 1 year low share price is currently 295p.
There are currently 106,896,552 shares in issue and the average daily traded volume is 767,519 shares. The market capitalisation of Jtc is £416,896,552.80.
jtcod: It's incredible think that despite 60%+ share price rise in the last 7 months Amazon is still on a current PE of 200+. It has been impervious to the market unrest too it seems.
tewkesbury: Powerhouse Energy (PHE) possible 2000 bagger: englishlongbow 25 May '18 - 10:49 - 6554 of 6556 Keith Allaun says PHE could be a FTSE 100 company based on their UK rollout plans i.e. at least 300p share price; and they are expecting 2.5x more rollout in the EU, and roll out in other geographies like Australia, Far East, Midddle East, etc. So in terms of the share price: 300p for the UK + 750p for the EU + more elsewhere, gives an eventual share price well over 1000p (£10) making it a 2000+ bagger from here. £1000 investment now could be worth £2 million in future. That is a mind boggling return on investment.
mount teide: serratia - the AsiaMet management's systematic approach to creating value will see the continued proving up of the future potential of the asset portfolio, while using the strong predicted cash flows generated from the proposed near term BKM 25,000t a year copper development, to drive the further resource evaluation and phased development of the much larger Beutong prospect. On a two year view, the valuation has the potential to be multiples of the current share price. The material news that is likely to drive the valuation will be an updated Jorc and scoping study for Beutong in H1 2019. Logically, with at least 6 times the current resource of BKM, the NPV will be north of $1.2 billion - assuming the market values only 20% of the NPV, at $240 million/£200 million this provides for circa 22p/share. Assuming BKM moves, post finance in H2/2018, toward a $200 million NPV, after deduction for some dilution, allow say £120 milllion or 14p/share. Add in the BKZ JORC and further drilling around KSK of say 4p/share and a sum of parts value of circa 40p is possible within the next 12-15 months. Additionally, its possible that a successful finance and mine build at BKM will enable the market to value Beutong at a greater percentage of the scoping NPV; so 40p could be conservative. The KSK Asset has the BKM Copper Deposit, a 25,000tpa cathode copper development at definitive feasibility stage (expected in Q2/2018) with significant resource upside potential nearby. Its a low capex, very low opex, likely readily financeable project that a report by mine development specialists Hackman & associates suggests could be brought into first production as early as H1/2020. According to the management's 2018/19 operational plan, during the next 18 months, shareholders should know the full value of Beutong via a scoping study (with a better defined resource + metallurgy confirmation ), have BKM financed and under construction, a Jorc for BKZ, initial drill results for BKS/BKW, possible BK area porphyry confirmation and further resource evaluation of the outstanding Baroi prospect. In terms of current JORC size, Beutong is the one most likely to take the company up the value curve as its currently 6 times larger than BKM but, a year of focussed drilling at BK could well reveal 800m of high grade copper resource continuation between BKZ and BKM and a BK porphyry of similar magnitude to Beutong together with first drill results from a number of other prospects of similar potential to BKM. I would expect the real value to be seen here from mid 2019 onward when Beutong resource/scale and PEA is known, BKM is financed and is nearing production and we know more on the resources of the other KSK prospects. As the CEO said recently said an investment in ARS is about systematically creating value - 'we're in it for the long term, as this is where the big money will be made.' The management have done this type of development before in the region, taking Oxiana metals from a $3m junior into a $6bn major during the last commodity cycle recovery/boom phase during 2000-2008. The latest company presentation and last 2 years RNS's details the Management's participation in placings and prices paid, managements stake in the company and how the Board has taken incentivised share options in lieu of salary for nearly three years - it speaks highly about how well they have aligned shareholders interests with their own. AIMHO/DYOR
serratia: MT, A question if I may ? How do you value ARS ? I've had a preliminary look at the management - seems fine so far. Looked at the future supply/demand and it's in copper's favour (probable future shortage). Shortage of new exploration/mines. This points towards further research on ARS. My first approach is to look for measured and indicated resource levels. Next up what value to put on copper in the ground ? This link suggests $0.04/lb. hTTp:// I need to run through the figures again but that would seem give a value around the present M.Cap/share price. Is this all about proving up the future potential or do you suggest another route to valuations ?
the stigologist: #AOR AorTech hTtps:// share price : 44p shares o/s : 5.6m mkt cap : £2.4m balance sheet cash : $0.5m? (Dec 2017 RNS : $328k as of Nov 2017) annual cashflow : c.$0.2m? (H1 Interims : Net Cash from Op. $172k) high quality cashflow from IPR licensing/royalty business model optionality from potential licensing of breast implant/heart valve biocompatible materials potential for use of company as a RTO/shell vehicle ? "The tax losses within the accounts also makes AOR attractive to a prospective buyer, as with millions to play with this could well prove to tempting to a profit making organisation" "£23M will attract deal makers. @20% that's £4.6M Discount that by 50% TAX LOSS IS WORTH MORE THAN TODAYS MARKET CAP" chart looks like it's breaking out (note last breakout above 50 day MA in November 2017 preceded big December 2017 150%+ move)
the stigologist: #AOR AorTech hTtps:// share price : 44p shares o/s : 5.6m mkt cap : £2.4m balance sheet cash : $0.5m? (Dec 2017 RNS : $328k as of Nov 2017) annual cashflow : c.$0.2m? (H1 Interims : Net Cash from Op. $172k) high quality cashflow from IPR licensing/royalty business model optionality from potential licensing of breast implant/heart valve biocompatible materials potential for use of company as a RTO/shell vehicle ? "The tax losses within the accounts also makes AOR attractive to a prospective buyer, as with millions to play with this could well prove to tempting to a profit making organisation" "£23M will attract deal makers. @20% that's £4.6M Discount that by 50% TAX LOSS IS WORTH MORE THAN TODAYS MARKET CAP" chart looks like it's breaking out (note last breakout above 50 day MA in November 2017 preceded big December 2017 150%+ move) Limited shares in issue, very tightly held
billiondollarbrain: Immupharma (IMM) Phase III Lupuzor results expected this week. Possible $ multi-billion blockbuster could lead to a massive re-rating of the share price. This promising small-cap stock could be a millionaire maker in 2018 Paul Summers 26/12/2017 hTTps:// The suggestion that a single stock could lead some investors to become millionaires next year may sound fanciful but I think this is quite possible if events work out for small-cap drug discovery and development firm ImmuPharma (LSE: IMM). Let me explain. Blockbuster potential Over the last three months, shares in the AIM-listed company have climbed more than 200% in value as anticipation grows over the outcome of a Phase III clinical trial for Lupuzor — its 100%-owned potential treatment for Lupus. Approximately five million people are believed to suffer from the chronic and potentially life-threatening autoimmune disease that can be a notoriously difficult to treat. In the last 50 years, only one therapy — GlaxoSmithKline‘s Benlysta — has been approved for use, despite its questionable efficacy and serious side-effects. In 2015, the drug achieved sales of over $400m. By 2020, this figure is expected to rise to $1bn. Positively, data from Lupozor’s Phase IIb trial indicated that ImmuPharma’s treatment — which modulates rather than blocks the immune system — was both effective and safe. Moreover, the effectiveness of Lupuzor increased even after the three-month trial’s conclusion. Investors will be hoping that the 52-week, randomised and double-blinded study currently in progress (involving patients in the US, Europe and Mauritius) yields similar results. In its most recent update on 21 December, the company revealed that all 200 participants had now received the full 12-month dosage and that the “robust safety record” shown in earlier trials continues to be seen. According to Chairman Tim McCarthy, the company looks forward “with continued confidence” to reporting on top-line results in Q1 of next year. In the event of a positive outcome, ImmuPharma will then seek to exploit its Fast Track designation and push for approval from the Food and Drug Administration (FDA). Once received, the company would then be free to seek out a global licensing deal for taking Lupuzor to market or — perhaps more likely — consider takeover bids by deep-pocketed pharmaceutical giants at a price befitting its blockbuster potential. Given the suggestion that it could be used in the treatment of other diseases, the price could easily be in the billions of pounds. Right now, ImmuPharma’s market cap is a little over £200m. Tempted? If so, it’s vital to consider the flip side of this investment. Despite the encouraging outcomes of previous trials, the possibility of the drug failing to impress still remains. Plenty of highly promising treatments have disappointed at the last hurdle, resulting in significant capital losses for investors. Unless you’re willing to embrace this level of risk, Immupharma shouldn’t even make it on to your watchlist, let alone into your portfolio. That’s why — as a holder of its stock — only a small proportion of my capital is invested in the company. This money can be lost. I might grumble and curse but — thanks to a degree of diversification — I won’t lose my shirt. That said, if — and it remains a sizeable ‘if‘ — Lupuzor proves effective (or at least more efficacious than Benlysta), I’m confident that ImmuPharma could generate huge wealth for investors in a very short time period. No investment is devoid of risk but only you can decide whether this is one worth taking.
mount teide: Thanks JT. Interesting to see the impact (speed and scale) that rising base metal prices is already having in turning around the fortunes of the industry. Glencore's straight talking CEO Ivan Glasenberg said recently; "what a difference a year of rising prices makes" - his results announced today certainly confirm that with pre-tax profits propelled to $6.9bn in 2017 from a loss in 2016. Debt fell by a third as, like other major base metal producers, Glencore continues to focus like a laser on lowering borrowings and rewarding with large dividend payments, shareholders who kept the faith during the long downturn. 'Glencore rewards investors with £2bn in dividends after ‘strongest’ year hTTp:// Mining group and commodity trader Glencore has hailed its “strongest” year on record and announced it would pay shareholders $2.9bn (£2.07bn) in dividends. The company will pay out $0.20 a share in two equal payments in 2018. It came as it reported that pre-tax profits in 2017 surged to $6.9bn from a loss of $549m the year before. Revenue jumped 25pc to $205bn on the back of higher prices for its key products, such as copper, coal, zinc and cobalt. Glencore’s earnings before interest, tax, depreciation and amortisation – a figure closely watched by the City – jumped 44pc to $14.7bn. It was helped by a strong performance in its “marketing” arm, which ships commodities around the globe. Earnings in this division hit $3bn, ahead of guidance, its best performance since 2008. The miner’s debt pile fell by almost a third in 2017 to $10.67bn, the bottom end of its guidance, as it stuck religiously to a commitment to lower its borrowings. Net debt had stood as high as $37bn in 2014 after its merger with Xstrata, and threatened to collapse on top of it in 2015, when investors took fright at Glencore’s balance sheet and the share price plunged. Ivan Glasenberg, the FTSE 100 giant’s billionaire chief executive and second largest shareholder, said that higher commodity prices and a tight control on costs had “enhanced mining margins”. “We look to the future with confidence. We believe our unrivalled positioning in ‘Tier 1’ commodities and ‘Tier 1’ assets will continue to create compelling value for all stakeholders,” he said. Glencore is one of the world’s biggest producers of copper and cobalt, both of which are expected to be in high demand for electric vehicles and batteries.'
jtcod: Falling share prices are a given whenever the point of probability becomes more pronounced in affairs related to nationalisation. Railtrack was a prime example. It's not the share price that matters it's the balance sheet. Because the government would face strong legal opposition should they try to pay less than net assets. Nobody is looking at the balance sheets yet except those with the power to manipulate them. This is why I was looking at National Grid. The time to nationalise NG. was 9 years ago when the assets were £4bn not now that they have been trumped up to £20bn. The part-sale of the Gas Transit network last year which added £7bn to the balance sheet is no coincidence imo. If we strip that out NG. Has been free cash flow negative ever since the financial crises. This was ignored by the management as debt (£27bn) was also ignored. If NG. is nationalised any idea that it will deliver improved service without greater cash injection from the tax payer is living in a dream world. I'd like to see the faces on treasury officials when they realise what they have inherited.
mount teide: Shipping / Industrial Metals Sectors In H1/2016 after waiting nearly 8 years for the Baltic Dry Index(-98%) to finally make a bottom, Copper(-56%), Zinc(-66%) and oil(-76%) as expected, also made a bottom within a few months of the BDI - not altogether unsurprising since 95% of all commodity production sees the bottom of a ships cargo hold at some stage between the mine/oil field and refiner/manufacturer. This was the signal I had been waiting for to go in extremely heavily in the copper/zinc/oil/shipping sectors - and continued to average up aggressively in 2017 by reversing out of long term positions in other sectors as the commodity sector cyclical recovery continues to gather pace. This early stage industrial metals cyclical recovery is different from almost all previously - since a decade low Warehouse Inventory situation and supply/demand deficit situation has developed within the first two years of recovery - something that took much longer in previous recovery phases. This occurred mainly as a consequence of a waterfall drop off in production development over the previous decade to preserve cash, almost complete cessation of exploration, industrial action at the major mines in Chile and Peru and a material drop off in ore grades/increase in operating costs at the principal global scale mines. Since the industrial metals/shipping sectors are highly cyclical over very long time periods - once the tide turns they are as close to a one way bet for years as the equity market throws up. Baltic Dry Index 1985-1994 - Recovery/Boom 1994-1999 - Recession 1999-2008 - Recovery/Boom 2008-2016 - Recession 2016-2024/5?- Recovery/Boom Predictably, the Copper chart has followed an almost identical pattern. The good news is that we are still in the foothills regarding recovery of the BDI and Copper prices - they are still 90% and 42% respectively below their previous cyclical highs. In the last recovery phase 1999-2008 Clarksons (CKN) share-price went from £0.90 to nearly £10.00 - those who sold in 2001/2 after doubling their money missed out on a further 800% of their original investment. Lloyd's List Intelligence in a special report published today described the global economic outlook as ‘best for shipping in a decade’ My main LTBH selections to play the industrial metals and shipping markets recovery phase over the next 3-5 years are Clarksons (CKN), Central Asian Metals (CAML) and Asia Met (ARS). Shipping - Clarksons CKN I'm expecting the BDI to be at circa 3,500 by the end of 2019/early 2020, that's nearly 250% higher than today but still just 29.6% of the 2008 all-time high of the last shipping cycle. If someone said to me that you could either have £30k of Clarkson's shares today(with a 2024 lock up period) or £100k cash in 2024 the likely peak of the new shipping sector recovery/boom phase - it would not be a difficult decision - i'd take the £30k of Clarkson's shares in a heartbeat! Why?, because Clarkson's ship-broking revenue is generated from a fixed percentage of a ship's charter contract. Most of the world's dry bulk/oil tanker/product tanker shipping fleet today is operating in the short term spot market - so as charter rates rise Clarkson's commission/revenue earned from each new ship charter rises in direct proportion. The scale of the last shipping recession was totally without precedent since the global shipping market is one of the few traded markets left that is not to a significant extent manipulated/controlled for political/financial/commercial purposes by major Nations. In UK property market terms the waterfall drop of the BDI between 2008 and 2016 was equivalent to a house falling in price from £200,000 to under £5,000! Its the reason why the valuations of ALL the main market US quoted shipping companies were decimated - with valuation losses averaging 95%-99% for those that avoided filing for Chapter 11 Protection or went bankrupt. The German KG Pension Fund Industry and shipping banks were also similarly destroyed by going into shipping at/close to the top of the markets - their combined losses were recently estimated by Lloyds List in excess of 100 billion Euros. Industrial Metals - Copper/Zinc Central Asian Metals CAML CAML is a very rare bird in the mining sector - an incredibly well managed, low operating cost, high cash generating, high dividend paying mining sector company which has demonstrated to the market it can make serious money and grow the dividend even in the depths of the worst recession to hit the sector for decades - a recession so brutal it brought most main market mining sector titans like Glencore and Anglo American to their knees - Glencore lost 85%+ of its valuation, and were forced to suspend the dividend and heavily dilute its shareholders with a huge placing to strengthen its balance sheet. While all this was going on CAML sailed serenely on and acted more like a dividend paying, safe haven, heavyweight FTSE company should act during a recession than ANY of the so called dividend paying, 'safe' haven FTSE heavyweights actually did! Unlike previous mining sector recessions, by the second year of recovery in the sector, Zinc, Lead and Copper are already at/close to deficit with warehouse stocks at/or close to decade lows due to mine closures, bankruptcies, smart use of mine shut-ins and a near 70% drop since 2013 in capital expenditure developing new production. Exploration dropped by over 90% during the last half decade. hTTp:// - decade low LME Warehouse stocks Add into this mix IMF Global GDP forecast uplifts to nearly 4% for 2018 and 2019, together with the US announcing a record programme of tax cuts and the opening of the capital expenditure floodgates on an unprecedented scale to rebuild their crumbling infrastructure. Add in the rapidly growing demand for industrial metals from the electric car and renewable energy sectors and India with a population almost identical to China (1.4 billion) commencing a huge countrywide infrastructure modernisation programme. Collectively, that lot is the perfect storm brewing for many years of strong demand and high prices. CAML as a low cost operator is incredibly well placed to do well during the recovery stage of the commodity cycle - The previous owner of recent acquisition the Zinc/Lead SASA mine made 100% profit in just over a year of ownership - and the price CAML paid in October 2017 is already looking a bargain since it was based largely on the 2016 accounts - Zinc and Lead pricing has gone up over 150% and 50% respectively following the recession lows in 2016. Peel Hunt(issued 10 Jan 2018) currently has EPS for 2018 of 38.3p and dividend of 19.31p(6.4%) giving a PE ratio of 7.9. If current metal pricing is maintained throughout 2018 the PE ratio drops to 6.2 The recovery of the global mining industry has seen valuations of most mining companies surge off the lows during 2017 - the 102 US quoted mining companies currently have the following combined PE Ratio's: 18.83/Forward - 52.11/Trailing London quoted Copper sector heavyweight Antofagasta currently has a trailing PE ratio of 58.19. All of which probably explains why CAML management had to run their slide rule over 150 companies during the last three years before finding one priced to their taste. And makes CAML's 2018 earnings with a forward PE ratio of 6.2 to 7.9 and trailing of 12.5 look mis-priced by comparison. The CAML valuation is difficult to ignore on a pure value level - and should a decent chunk of the valuation gap fail to close over the next 12 months, will leave the company a prime target for a market that is now experiencing a rising trend of M&A activity Asia Met ARS There is probably no better example in the mining sector than Asia Met of how the brutal 8 year recession in the industrial metal markets through to early 2016, decimated global production development and effectively brought exploration by the majors to a complete standstill for nearly half a decade. Posts 11248 and 10725 on the ARS thread gives a little background - so impressed with the potential of the world class ARS assets and discoveries found by exploration entirely funded by sector major Freeport, were the new Australian management who took over ARS in 2015: ALL the Board (Execs and Non Execs) have collectively elected to take their entire 'remuneration/fees' since as share-price incentivised stock options, thereby fully aligning themselves with shareholders to an extent I have never seen before in any company - three years of paying their own and families living expenses out of their own pockets is making a huge statement. How were they able to do this? Some like ARS CEO Tony Manini were instrumental in taking Oxiana Metals an Australian junior miner from a company worth $3m to $6bn during the previous 2000-2008 sector recovery/boom phase. Tony recently said, he managed to take Oxiana to a $6bn valuation by doing what he’s doing with Asiamet right now. No investment advice offered, intended or inferred. AIMHO/DYOR Note: After being way behind the curve for over 18 months a number of major US investment banks turned full circle and issued very significant upgrades last week to their 2018 Industrial metal price forecasts: Copper $8,000/t - $3.60/lb - Goldman Sachs - by year end $7,750/t - $3.52/lb - Bank of America - by mid year £7,175/t - $3.26/lb - Citigroup - Average for year $6,788/t - $3.08/lb - Current price $6,193/t - $2.81/lb - 2017 Average Price $4,848/t - $2.21/lb - 2016 Average price(copper made a bottom/8 year low in March).
Jtc share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20180623 00:42:31